Tapering Lupus Drugs in Stable Patients: Flare Risks Studied Tapering Lupus Drugs in Stable Patients: Flare Risks Studied

Tapering is best reserved for those in complete remission with stable disease for at least 6 months, although many individual patient characteristics must be taken into account, experts say.MDedge News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news